Endocrine Society GUIDELINES Bundle (free trial)

Lipid Management in Endocrine Disorders

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1356565

Contents of this Issue


Page 1 of 21

Key Points 2 ➤ Obtain a lipid panel in adults with endocrine disorders to assess triglyceride (TG) levels and to calculate LDL cholesterol (LDL-C). ➤ Treat adults with type 2 diabetes (T2D) and other cardiovascular (CV) risk factors with a statin in addition to lifestyle modifications, aiming for an LDL-C goal of <70 mg/dL. ➤ Consider statin therapy, irrespective of the CV risk score, in adults with type 1 diabetes who are age 40 years and older, or have a history of diabetes of at least 20 years, or either microvascular complications, chronic kidney disease (CKD) stages 1-4, or obesity. ➤ Rule out hypothyroidism in patients with hyperlipidemia before treatment with lipid lowering medications. In patients with hypothyroidism re- evaluate the lipid profile when the patient is euthyroid. ➤ Consider statin therapy as adjunct to lifestyle modifications in adults with persistent endogenous Cushing's syndrome or adults taking chronic glucocorticoid therapy above replacement levels. ➤ For treatment of dyslipidemia in post-menopausal women, use statins, rather than hormone therapy, because statins reduce atherosclerotic cardiovascular disease (ASCVD). ➤ Evaluate and treat lipids and other CV risk factors in women who enter menopause early (before the age of 40-45 years). Assessment 1. Screening and Cardiovascular Disease Risk Assessment Measurement of Lipids ➤ 1.1 In adults with endocrine disorders, we recommend a lipid panel for the assessment of TG levels and for calculating LDL-C. (1|⊕⊕⊕ ) Technical Remarks: ▶ Non-fasting lipid panels are acceptable for initial screening. ▶ If TG levels are elevated or if genetic dyslipidemia is suspected, repeat a fasting lipid panel. ▶ If lipoprotein(a) [Lp(a)] levels are measured, fasting or non-fasting samples can be obtained.

Articles in this issue

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Lipid Management in Endocrine Disorders